Market Cap 268.08M
Revenue (ttm) 14.56M
Net Income (ttm) -63.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -436.33%
Debt to Equity Ratio 0.00
Volume 1,112,300
Avg Vol 1,460,014
Day's Range N/A - N/A
Shares Out 252.91M
Stochastic %K 11%
Beta 1.53
Analysts Strong Sell
Price Target $5.14

Company Profile

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; and OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for th...

Industry: Biotechnology
Sector: Healthcare
Phone: 442 287 8990
Address:
2173 Salk Avenue, Suite 200, Carlsbad, United States
JohnPDaly
JohnPDaly Aug. 19 at 1:40 PM
$LCTX There is a tide in the affairs of men Which, taken at the flood, leads on to fortune; Omitted, all the voyage of their life Is bound in shallows and in miseries. On such a full sea are we now afloat; And we must take the current when it serves, Or lose our ventures. William Shakespeare , Julius Caesar
0 · Reply
Ablidy
Ablidy Aug. 19 at 5:06 AM
$LCTX PRlog from Saltusbiotech , bio manufacturing the golden jewel of biotech
1 · Reply
Ablidy
Ablidy Aug. 19 at 1:56 AM
1 · Reply
buckheads923
buckheads923 Aug. 18 at 8:08 PM
$LCTX someone riddle me why 143 doses were shipped. My college roomate and his girlfriend would say it to each other all the time. Code for “ I LOVE YOU”. 1-4-3 letters. Must be more to why not 144. A dozen cases of a dozen. Did someone drop a vial? Lol
3 · Reply
Trak2
Trak2 Aug. 18 at 7:24 PM
$LCTX the royalties from the eye drug alone would be in the billions, so why would we sell the company for two or 3 billion? plus 615 million,patience.
0 · Reply
Ablidy
Ablidy Aug. 18 at 6:23 PM
$LCTX let go $LCTX Google Andrew Caravello immune teeter totter , and fine out the operational manual to immune system anti aging , cancer , autoimmune,…….and cell manufacturing is Crown Jewels , The CEO of $ROCHE cries on Linked in about EU losing out to China to single digits And USA losing to but still in lead , this is for another day. ….any what is $ROCHE going to do? Merck bought Biotechne for $ 11 billion whaypt is $ LCTX ….Remember the date 7-30-2026 the date that the operation manual was published in Frontiers in Immunology …..the hand writing is on the wall…cellular with Biological Reboot or obsolete for the pill popping business plan….game over and they know it in Basal Why is this share price for $LCTX this price MM and Wall Street?
1 · Reply
imatisse
imatisse Aug. 18 at 4:18 PM
$LWLG #bottleneck As soon as we have 1 deal, hell will break loose. $LCTX #bottleneck As soon as we have 1 deal, hell will break loose
1 · Reply
alphadog10
alphadog10 Aug. 18 at 3:54 PM
$LCTX Broadwood who?
0 · Reply
sfoblader
sfoblader Aug. 18 at 3:44 PM
$LCTX Those considering the chances of a Roche buyout, timing and price should watch two LCTX projects - (1) Islet cell mass production and (2) COR1 cell production. These programs, if successful, would expand Roche’s ophthalmology and diabetes pipelines. And, it would undeniably prove the massive potential of LCTX ‘s cell therapy/production platform making an acquisition price well north of 15 billion dollars possible.
2 · Reply
alphadog10
alphadog10 Aug. 18 at 3:42 PM
$LCTX This criminal enterprise dont want no smoke with the dog !
0 · Reply
Latest News on LCTX
Lineage Cell Therapeutics Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Lineage Cell Therapeutics Earnings Call Transcript: Q2 2026


Lineage Cell Therapeutics Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Lineage Cell Therapeutics Earnings release: Q2 2026


Lineage Cell Therapeutics Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Lineage Cell Therapeutics Quarterly report: Q2 2026


Lineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c)

2026-08-06T20:17:34.000Z - 12 days ago

Lineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c)


Lineage Cell Therapeutics Transcript: Study update

Jul 13, 2026, 4:30 PM EDT - 5 weeks ago

Lineage Cell Therapeutics Transcript: Study update


Lineage Cell Therapeutics Press release: Study update

Jul 13, 2026, 4:30 PM EDT - 5 weeks ago

Lineage Cell Therapeutics Press release: Study update


Lineage Cell Therapeutics provides update on COR1 program

2026-07-13T12:05:45.000Z - 5 weeks ago

Lineage Cell Therapeutics provides update on COR1 program


Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)

2026-05-12T22:11:23.000Z - 3 months ago

Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)


Lineage Cell Therapeutics Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Lineage Cell Therapeutics Earnings Call Transcript: Q1 2026


Lineage Cell Therapeutics Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Lineage Cell Therapeutics Earnings release: Q1 2026


Lineage Cell Therapeutics Quarterly report: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Lineage Cell Therapeutics Quarterly report: Q1 2026


Lineage Cell Therapeutics Slides: Corporate presentation

May 12, 2026, 7:00 AM EDT - 3 months ago

Lineage Cell Therapeutics Slides: Corporate presentation


Lineage Cell Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Lineage Cell Therapeutics Proxy statement: Proxy filing


Lineage Cell Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Lineage Cell Therapeutics Proxy statement: Proxy filing


Lineage Cell Therapeutics initiated with a Buy at Canaccord

2026-04-28T11:14:03.000Z - 4 months ago

Lineage Cell Therapeutics initiated with a Buy at Canaccord


Lineage Announces Formation of Scientific Advisory Board

Apr 13, 2026, 8:00 AM EDT - 4 months ago

Lineage Announces Formation of Scientific Advisory Board


Lineage Cell Therapeutics management to meet with Craig-Hallum

2026-04-08T20:56:34.000Z - 4 months ago

Lineage Cell Therapeutics management to meet with Craig-Hallum


Lineage Cell Therapeutics Slides: Corporate presentation

Mar 25, 2026, 7:00 AM EDT - 5 months ago

Lineage Cell Therapeutics Slides: Corporate presentation


Lineage Cell Therapeutics Earnings Call Transcript: Q4 2025

Mar 5, 2026, 4:30 PM EST - 5 months ago

Lineage Cell Therapeutics Earnings Call Transcript: Q4 2025


Lineage Cell Therapeutics Annual report: Q4 2025

Mar 5, 2026, 4:30 PM EST - 5 months ago

Lineage Cell Therapeutics Annual report: Q4 2025


Lineage Cell Therapeutics Earnings release: Q4 2025

Mar 5, 2026, 4:30 PM EST - 5 months ago

Lineage Cell Therapeutics Earnings release: Q4 2025


Lineage Cell Therapeutics reports Q4 EPS 0c vs (2c) last year

2026-03-05T21:11:09.000Z - 5 months ago

Lineage Cell Therapeutics reports Q4 EPS 0c vs (2c) last year


Lineage Cell Therapeutics management to meet with B, Riley

2026-02-20T14:15:55.000Z - 6 months ago

Lineage Cell Therapeutics management to meet with B, Riley


Lineage Cell Therapeutics Issues Letter to Stockholders

Jan 5, 2026, 8:00 AM EST - 8 months ago

Lineage Cell Therapeutics Issues Letter to Stockholders


Lineage Cell Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Lineage Cell Therapeutics Earnings Call Transcript: Q3 2025


Lineage Cell Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Lineage Cell Therapeutics Quarterly report: Q3 2025


Lineage Cell Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Lineage Cell Therapeutics Earnings release: Q3 2025


Lineage Cell Therapeutics reports Q3 EPS (13c), consensus (3c)

2025-11-06T21:12:07.000Z - 10 months ago

Lineage Cell Therapeutics reports Q3 EPS (13c), consensus (3c)


Lineage Cell Therapeutics Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Earnings Call Transcript: Q2 2025


Lineage Cell Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Quarterly report: Q2 2025


Lineage Cell Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Earnings release: Q2 2025


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Jun 11, 2025, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Earnings Call Transcript: Q1 2025


Lineage Cell Therapeutics Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Quarterly report: Q1 2025


Lineage Cell Therapeutics Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Earnings release: Q1 2025


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Earnings Call Transcript: Q4 2024

Mar 10, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Earnings Call Transcript: Q4 2024


Lineage Cell Therapeutics Annual report: Q4 2024

Mar 10, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Annual report: Q4 2024


Lineage Cell Therapeutics Earnings release: Q4 2024

Mar 10, 2025, 4:30 PM EDT - 1 year ago

Lineage Cell Therapeutics Earnings release: Q4 2024


Lineage Cell Therapeutics Slides: FY 2025

Feb 11, 2025, 12:40 PM EST - 1 year ago

Lineage Cell Therapeutics Slides: FY 2025


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Dec 9, 2024, 7:00 AM EST - 1 year ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Proxy statement: Proxy Filing

Nov 29, 2024, 7:00 AM EST - 1 year ago

Lineage Cell Therapeutics Proxy statement: Proxy Filing


Lineage Cell Therapeutics Earnings Call Transcript: Q3 2024

Nov 14, 2024, 4:30 PM EST - 1 year ago

Lineage Cell Therapeutics Earnings Call Transcript: Q3 2024


Lineage Cell Therapeutics Quarterly report: Q3 2024

Nov 14, 2024, 4:30 PM EST - 1 year ago

Lineage Cell Therapeutics Quarterly report: Q3 2024


Lineage Cell Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 4:30 PM EST - 1 year ago

Lineage Cell Therapeutics Earnings release: Q3 2024


Lineage Cell Therapeutics Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Earnings Call Transcript: Q2 2024


Lineage Cell Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Quarterly report: Q2 2024


Lineage Cell Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Earnings release: Q2 2024


Lineage to Present at 2024 BIO International Convention

May 30, 2024, 8:00 AM EDT - 2 years ago

Lineage to Present at 2024 BIO International Convention


Lineage Cell Therapeutics Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Earnings Call Transcript: Q1 2024


Lineage Cell Therapeutics Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Quarterly report: Q1 2024


Lineage Cell Therapeutics Earnings release: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lineage Cell Therapeutics Earnings release: Q1 2024


JohnPDaly
JohnPDaly Aug. 19 at 1:40 PM
$LCTX There is a tide in the affairs of men Which, taken at the flood, leads on to fortune; Omitted, all the voyage of their life Is bound in shallows and in miseries. On such a full sea are we now afloat; And we must take the current when it serves, Or lose our ventures. William Shakespeare , Julius Caesar
0 · Reply
Ablidy
Ablidy Aug. 19 at 5:06 AM
$LCTX PRlog from Saltusbiotech , bio manufacturing the golden jewel of biotech
1 · Reply
Ablidy
Ablidy Aug. 19 at 1:56 AM
1 · Reply
buckheads923
buckheads923 Aug. 18 at 8:08 PM
$LCTX someone riddle me why 143 doses were shipped. My college roomate and his girlfriend would say it to each other all the time. Code for “ I LOVE YOU”. 1-4-3 letters. Must be more to why not 144. A dozen cases of a dozen. Did someone drop a vial? Lol
3 · Reply
Trak2
Trak2 Aug. 18 at 7:24 PM
$LCTX the royalties from the eye drug alone would be in the billions, so why would we sell the company for two or 3 billion? plus 615 million,patience.
0 · Reply
Ablidy
Ablidy Aug. 18 at 6:23 PM
$LCTX let go $LCTX Google Andrew Caravello immune teeter totter , and fine out the operational manual to immune system anti aging , cancer , autoimmune,…….and cell manufacturing is Crown Jewels , The CEO of $ROCHE cries on Linked in about EU losing out to China to single digits And USA losing to but still in lead , this is for another day. ….any what is $ROCHE going to do? Merck bought Biotechne for $ 11 billion whaypt is $ LCTX ….Remember the date 7-30-2026 the date that the operation manual was published in Frontiers in Immunology …..the hand writing is on the wall…cellular with Biological Reboot or obsolete for the pill popping business plan….game over and they know it in Basal Why is this share price for $LCTX this price MM and Wall Street?
1 · Reply
imatisse
imatisse Aug. 18 at 4:18 PM
$LWLG #bottleneck As soon as we have 1 deal, hell will break loose. $LCTX #bottleneck As soon as we have 1 deal, hell will break loose
1 · Reply
alphadog10
alphadog10 Aug. 18 at 3:54 PM
$LCTX Broadwood who?
0 · Reply
sfoblader
sfoblader Aug. 18 at 3:44 PM
$LCTX Those considering the chances of a Roche buyout, timing and price should watch two LCTX projects - (1) Islet cell mass production and (2) COR1 cell production. These programs, if successful, would expand Roche’s ophthalmology and diabetes pipelines. And, it would undeniably prove the massive potential of LCTX ‘s cell therapy/production platform making an acquisition price well north of 15 billion dollars possible.
2 · Reply
alphadog10
alphadog10 Aug. 18 at 3:42 PM
$LCTX This criminal enterprise dont want no smoke with the dog !
0 · Reply
alphadog10
alphadog10 Aug. 18 at 3:35 PM
$LCTX This is the most fun I've had since culley said OPC-1 was going pivotal in 2022
0 · Reply
TheBigEman
TheBigEman Aug. 18 at 3:17 PM
$LCTX I don't think LCTX will ever see another milestone payment from Roche. Just guessing that transitioning to Phase 3 is a major payment....ie. far more than the 5M previously paid (maybe 50M), and even the most jaded investors / critics of LCTX would have to take notice, driving the share price up for more than the actual milestone payment. Roche would rather buy them out before the payment. And I don't think the buyout price is super high either. I'm not in the camp believing we are worth billions and billions. Maybe in several years IF opregen is booming, and other therapies are underway, we are well known acknowledged cell manufacturing leaders, etc, etc.
7 · Reply
wblb
wblb Aug. 18 at 12:31 PM
$LCTX Could be a bumpy few months into mid terms. Average draw down in mid term years is 10%. Without news, which isn't happening, my guess is lctx could see .85.
1 · Reply
Gromit00
Gromit00 Aug. 18 at 3:42 AM
$LCTX been almost a month since Roche has put out a media release. Could we wake up one morning soon with the headline “Roche to acquire Lineage Cell Therapeutics in $16B deal”.
2 · Reply
alphadog10
alphadog10 Aug. 17 at 4:33 PM
$LCTX Records follow people, whether that be destroying Biotech companies from the CEO position an inability to produce good outcomes or Breach of fiduciary duties of controlling board members. The best part is, Its right there in black and white all public knowledge.
1 · Reply
alphadog10
alphadog10 Aug. 17 at 4:28 PM
$LCTX Breacher up ! Breacher, Breacher
1 · Reply
JohnPDaly
JohnPDaly Aug. 17 at 4:22 PM
$LCTX I did not get a response from Investor Relations at Roche. Anyone?Thanks.
2 · Reply
smzal
smzal Aug. 17 at 2:00 PM
$LCTX @alphadog10 I ’ve already asked—without getting an answer—what’s with the fixation on Culley? If it were me, I’d hire the most expensive lawyer and sue for stalking.
5 · Reply
JohnPDaly
JohnPDaly Aug. 17 at 1:31 PM
$LCTX Mon Dieu!
0 · Reply
tiddyy
tiddyy Aug. 17 at 12:56 PM
$LCTX $EYPT busted open, not the same type of AMD but wow
0 · Reply
alphadog10
alphadog10 Aug. 17 at 11:18 AM
$LCTX Destroying biotech companies , now thats cool ! 🤭
0 · Reply
alphadog10
alphadog10 Aug. 17 at 11:16 AM
$LCTX band is not cool, Running is even less cool. I smell a Cambrian explosion in non-coolness 👃
2 · Reply